Join the DSI team in Boston on September 28-29, 2022 at Biopharm America!
We’re excited to be back in-person at BPA this year. For 2022, the conference is also providing two virtual days, October 4-5, 2022, for those unable to attend the conference in-person. We will be participating in the conference for both the virtual and in-person dates. DSI welcomes both avenues of meetings and looks forward to chatting with your team to explore our potential synergies.
About DS InPharmatics
DSI is a full-service regulatory drug development consulting firm for pharmaceuticals, biologics and new drug and delivery platforms. DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and next generation therapy products.
Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.
Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.
Connect with DS InPharmatics on LinkedIn or visit www.dsinpharmatics.com for more information.
CONTACT:
Meranda Parascandola
Head of Business Development and Marketing
Mparascandola@dsinpharmatics.com
Design Space InPharmatics, llc. (DSI)
Tel: (855) 805-8402×104
